Why should pharma companies rethink strategies that already work? In this episode of Pharma Talks, Nataliya Andreychuk is joined by Tara DeBellis to discuss why changes in the pharmaceutical industry are no longer optional but necessary for growth and sustainability.

From evolving life sciences strategy to addressing regulatory changes and patient expectations, Nataliya and Tara uncover the signs that it's time to evolve.

You'll learn:

• How to spot early warning signs that your processes are holding back innovation.

• Why pharma transformation isn't just about tools, but about smarter collaboration, omnichannel orchestration, and rethinking campaign execution.

• Common myths about digital health and pharma trends, and how to separate hype from meaningful change.

• Real-world lessons from healthcare marketing that highlight the risks of standing still.

This episode is a must-listen for leaders navigating pharmaceutical industry changes, life sciences innovation, and healthcare change in an era of fast-moving digital disruption.

Contact Viseven experts to elevate your healthcare marketing strategy: https://viseven.com/contact-us/

***

Follow Viseven, Nataliya, and Tara in social media: https://www.linkedin.com/company/viseven/

https://www.linkedin.com/in/andreychuk/

https://www.linkedin.com/in/tara-debellis-3476831bb/

***

🔗 Links for more insights:

https://viseven.com/pharma-change-management/

https://viseven.com/omnichannel/

https://viseven.com/digital-transformation-in-pharma/

https://viseven.com/7-core-components-of-successful-global-marketing-strategy/